| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999633 | Urologic Oncology: Seminars and Original Investigations | 2015 | 9 Pages |
Abstract
Our findings indicate that 6-sulfo sLeX glycans likely play 2 roles in bladder urothelial carcinoma progression: one in lymphocyte recruitment to enhance antitumor immune responses, and the other in E-selectin-mediated tumor cell adhesion to vascular endothelial cells, which is potentially associated with metastasis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Minekatsu M.D., Hitomi Ph.D., Shulin B.Sc., Yoshiaki M.D., Ph.D., Hideaki M.D., Ph.D., Osamu M.D., Ph.D., Motohiro M.D., Ph.D.,